1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MOONLAKE IMMUNOTHERAPEUTICS - ORDINARY SHARES - CLASS A
MoonLake Immunotherapeutics - Ordinary Shares - Class A XNAS: MLTX

MoonLake Immunotherapeutics (Class A) Live Stock Price Today, Share Analysis and Chart

about

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibit...

Read More
13.73 -0.07 (-0.51%)
78.12% Fall from 52W High
915.7K
XNAS Volume

XNAS 28 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Not Eligible
Valuation Score
Expensive Valuation
9.5 / 100
Momentum Score
Technically Bearish
25.1 / 100
Analyst Price Target
No estimates available

12

S

12

W

1

O

3

T

SWOT Analysis

MoonLake Immunotherapeutics (Class A) Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..